IBDQ — iShares iBonds Dec 2025 Term Corporate ETF
Data updated: 2026-01-14
IBDQ — iShares iBonds Dec 2025 Term Corporate ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Alternative · $2.74B AUM · 0.10% expense ratio · 4.6% 1-yr return. From SEC regulatory filings.
IBDQ Fund Overview
IBDQ — iShares iBonds Dec 2025 Term Corporate ETF is a US ETF managed by iSHARES TRUST, categorised as Alternative. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: iSHARES TRUST
- Category: Alternative
- Assets under management: $2.74B
- 1-year return: 4.6%
- Ticker: IBDQ
- SEC CIK: 0001100663
- SEC series ID: S000048153
- Share class ID: C000152180
IBDQ Holdings
Top 10 holdings of iShares iBonds Dec 2025 Term Corporate ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Blackrock Cash Funds Treasury Sl Agency Shares | 72.70% |
| Visa, Inc. | 2.05% |
| Microsoft Corp. | 1.50% |
| Ford Motor Credit Co. LLC | 1.03% |
| Astrazeneca PLC | 1.00% |
| Morgan Stanley | 0.95% |
| Dupont De Nemours, Inc. | 0.93% |
| Novartis Capital Corp. | 0.87% |
| Banco Santander SA | 0.72% |
| Lloyds Banking Group PLC | 0.62% |
IBDQ Portfolio Allocation
Asset-class allocation of iShares iBonds Dec 2025 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Cash & Equivalents | 72.7% |
| Fixed Income | 26.6% |
IBDQ Performance
Total returns for IBDQ (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 4.6% |
| 3 years (annualised) | 5.3% |
| 5 years (annualised) | 1.6% |
IBDQ Risk Information
Risk metrics for IBDQ, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 0.1%
IBDQ Costs and Fees
IBDQ costs about $10 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.10%
- Gross expense ratio: 0.10%
- Portfolio turnover: 4%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
IBDQ Cashflows
Over the 12 months to 2025-10, iShares iBonds Dec 2025 Term Corporate ETF had net outflows of $144.49M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2025-10 | −$30.27M |
| 2025-09 | −$95.56M |
| 2025-08 | −$70.38M |
| 2025-07 | −$56.55M |
| 2025-06 | −$74.14M |
| 2025-05 | −$31.39M |
IBDQ Debt Constituents
Largest debt holdings of iShares iBonds Dec 2025 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Visa, Inc. | 2.05% |
| Microsoft Corp. | 1.50% |
| Ford Motor Credit Co. LLC | 1.03% |
| Astrazeneca PLC | 1.00% |
| Morgan Stanley | 0.95% |
| Dupont De Nemours, Inc. | 0.93% |
| Novartis Capital Corp. | 0.87% |
| Banco Santander SA | 0.72% |
| Lloyds Banking Group PLC | 0.62% |
| Intercontinentalexchange | 0.61% |
IBDQ Prospectus and SEC Filings
Official iShares iBonds Dec 2025 Term Corporate ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Alternative funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.